The United States Patent and Trademark Office (USPTO) has recently granted US Patent No. 9080184 entitled “Transgenic Therapeutic Stem Cells and Methods for Their Use and Manufacture” to Stemedica Cell Technologies Inc. This patent contains extra amount of human granulyotic colony thus offering neuroprotection as well as neurogenesis.